Announcements

Dianthus Therapeutics, Inc. officer Ryan Savitz filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 124,042 shares of common stock acquired through the exercise of stock options.

A Form 144 notice of proposed sale was filed on November 9, 2026, by the Rezk Family Trust UAD 02/15/2022, disclosing a plan to sell 50,000 shares of common stock in Aeva Technologies, Inc. on NASDAQ.

Brad C. Brubaker, an officer of UiPath, Inc., filed a Form 144 notice on November 9, 2026, proposing the sale of 27,404 shares of UiPath common stock on the NYSE under a Rule 10b5-1 plan.

Director Jim Fasano of IQVIA Holdings Inc. filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of 154 deferred shares on November 5, 2026, under the company's Non-Employee Director Deferral Plan.

Jeffrey Raider, a director at Warby Parker, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 30,000 shares of Warby Parker common stock on NYSE under a Rule 10b5-1 plan.

Neil Blumenthal, a director and officer of Warby Parker Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 73,133 shares of Warby Parker common stock on the New York Stock Exchange.

Director Leslie Wims Morris of IQVIA Holdings Inc. filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of 125 deferred shares on November 5, 2026, at a price of $264.88 per share under the company's Non-Employee Director Deferral …